406 related articles for article (PubMed ID: 33972057)
1. Pediatric COVID toes and fingers.
Koschitzky M; Oyola RR; Lee-Wong M; Abittan B; Silverberg N
Clin Dermatol; 2021; 39(1):84-91. PubMed ID: 33972057
[TBL] [Abstract][Full Text] [Related]
2. Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms.
Cappel MA; Cappel JA; Wetter DA
Mayo Clin Proc; 2021 Apr; 96(4):989-1005. PubMed ID: 33714595
[TBL] [Abstract][Full Text] [Related]
3. Chilblain-like lesions on feet and hands during the COVID-19 Pandemic.
Landa N; Mendieta-Eckert M; Fonda-Pascual P; Aguirre T
Int J Dermatol; 2020 Jun; 59(6):739-743. PubMed ID: 32329897
[No Abstract] [Full Text] [Related]
4. Chilblains in children in the setting of COVID-19 pandemic.
Andina D; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I; Torrelo A
Pediatr Dermatol; 2020 May; 37(3):406-411. PubMed ID: 32386460
[TBL] [Abstract][Full Text] [Related]
5. COVID toes or pernio?
Zaladonis A; Huang S; Hsu S
Clin Dermatol; 2020; 38(6):764-767. PubMed ID: 33341212
[TBL] [Abstract][Full Text] [Related]
6. Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic.
Colonna C; Genovese G; Monzani NA; Picca M; Boggio F; Gianotti R; Marzano AV
J Am Acad Dermatol; 2020 Sep; 83(3):965-969. PubMed ID: 32534082
[No Abstract] [Full Text] [Related]
7. Chilblain-Like Lesions (CLL) Associated With COVID-19 ("COVID Toes"): A Systematic Review.
Kashetsky N; Mukovozov IM; Bergman J
J Cutan Med Surg; 2021; 25(6):627-633. PubMed ID: 33849305
[TBL] [Abstract][Full Text] [Related]
8. Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases.
Kanitakis J; Lesort C; Danset M; Jullien D
J Am Acad Dermatol; 2020 Sep; 83(3):870-875. PubMed ID: 32502585
[TBL] [Abstract][Full Text] [Related]
9. Paraviral eruptions in the era of COVID-19: Do some skin manifestations point to a natural resistance to SARS-CoV-2?
Lipsker D
Clin Dermatol; 2020; 38(6):757-761. PubMed ID: 33341210
[TBL] [Abstract][Full Text] [Related]
10. Going viral: A brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic.
Massey PR; Jones KM
Semin Oncol; 2020 Oct; 47(5):330-334. PubMed ID: 32736881
[TBL] [Abstract][Full Text] [Related]
11. Patient characteristics in tardive COVID-19 pseudoperniosis: a case series of 16 patients.
Ganatra B; Amarnani R; Alfallouji Y; Dear K; Twigg E; Westwood JP; Goulden B; Morris V; Hillman T; Goolamali S; Naderi Z; Sidwell R; Ellery P; Calonje E; Kravvas G; Bunker CB
Clin Exp Dermatol; 2022 Feb; 47(2):399-403. PubMed ID: 34411313
[TBL] [Abstract][Full Text] [Related]
12. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein.
Ko CJ; Harigopal M; Gehlhausen JR; Bosenberg M; McNiff JM; Damsky W
J Cutan Pathol; 2021 Jan; 48(1):47-52. PubMed ID: 32895985
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between pandemic chilblains and SARS-CoV-2 infection.
Gehlhausen JR; Little AJ; Ko CJ; Emmenegger M; Lucas C; Wong P; Klein J; Lu P; Mao T; Jaycox J; Wang E; ; Ugwu N; Muenker C; Mekael D; Klein RQ; Patrignelli R; Antaya R; McNiff J; Damsky W; Kamath K; Shon J; Ring AM; Yildirim I; Omer S; Ko AI; Aguzzi A; Iwasaki A
Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217624
[TBL] [Abstract][Full Text] [Related]
14. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.
Hubiche T; Cardot-Leccia N; Le Duff F; Seitz-Polski B; Giordana P; Chiaverini C; Giordanengo V; Gonfrier G; Raimondi V; Bausset O; Adjtoutah Z; Garnier M; Burel-Vandenbos F; Dadone-Montaudié B; Fassbender V; Palladini A; Courjon J; Mondain V; Contenti J; Dellamonica J; Leftheriotis G; Passeron T
JAMA Dermatol; 2021 Feb; 157(2):202-206. PubMed ID: 33237291
[TBL] [Abstract][Full Text] [Related]
15. An Autopsy Review: "COVID Toes".
Yilmaz MM; Szabolcs MJ; Geskin LJ; Niedt GW
Am J Dermatopathol; 2021 Aug; 43(8):554-555. PubMed ID: 33055537
[TBL] [Abstract][Full Text] [Related]
16. [COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2].
Yatim A; Gilliet M
Rev Med Suisse; 2021 Mar; 17(732):646-652. PubMed ID: 33793103
[TBL] [Abstract][Full Text] [Related]
17. A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.
Kolivras A; Thompson C; Pastushenko I; Mathieu M; Bruderer P; de Vicq M; Feoli F; Harag S; Meiers I; Olemans C; Sass U; Dehavay F; Fakih A; Lam-Hoai XL; Marneffe A; Van De Borne L; Vandersleyen V; Richert B
J Cutan Pathol; 2022 Jan; 49(1):17-28. PubMed ID: 34272741
[TBL] [Abstract][Full Text] [Related]
18. From Your Nose to Your Toes: A Review of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio.
Arkin LM; Moon JJ; Tran JM; Asgari S; O'Farrelly C; Casanova JL; Cowen EW; Mays JW; Singh AM; Drolet BA;
J Invest Dermatol; 2021 Dec; 141(12):2791-2796. PubMed ID: 34561087
[TBL] [Abstract][Full Text] [Related]
19. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
El Hachem M; Diociaiuti A; Concato C; Carsetti R; Carnevale C; Ciofi Degli Atti M; Giovannelli L; Latella E; Porzio O; Rossi S; Stracuzzi A; Zaffina S; Onetti Muda A; Zambruno G; Alaggio R
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2620-2629. PubMed ID: 32474947
[TBL] [Abstract][Full Text] [Related]
20. Chilblains and COVID-19: further evidence against a causal association.
Baeck M; Peeters C; Herman A
J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):e2-e3. PubMed ID: 32866323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
